BBA
Baker Bros. Advisors’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.78M | Sell |
2,485,018
-773,384
| -24% | -$866K | 0.03% | 72 |
|
|
2025
Q1 | $2.57M | Hold |
3,258,402
| – | – | 0.03% | 71 |
|
|
2024
Q4 | $5.38M | Buy |
3,258,402
+260,630
| +9% | +$430K | 0.06% | 66 |
|
|
2024
Q3 | $10.5M | Hold |
2,997,772
| – | – | 0.11% | 51 |
|
|
2024
Q2 | $9.83M | Buy |
2,997,772
+1,179,591
| +65% | +$3.87M | 0.13% | 48 |
|
|
2024
Q1 | $13.3M | Buy |
+1,818,181
| New | +$13.3M | 0.17% | 44 |
|
|
2023
Q3 | – | Sell |
-1,671,717
| Closed | -$7.96M | – | 103 |
|
|
2023
Q2 | $7.96M | Hold |
1,671,717
| – | – | 0.05% | 63 |
|
|
2023
Q1 | $9.53M | Buy |
1,671,717
+1,456,022
| +675% | +$8.3M | 0.05% | 55 |
|
|
2022
Q4 | $2.18M | Hold |
215,695
| – | – | 0.01% | 97 |
|
|
2022
Q3 | $4.83M | Buy |
+215,695
| New | +$4.83M | 0.03% | 82 |
|